Weight Management
Retatrutide
Research Use OnlyRetatrutide (LY3437943) is a novel triple-agonist peptide developed by Eli Lilly that simultaneously targets glucagon-like peptide-1 (GLP-1)…
Current batch
SEED-1- HPLC purity
- 99.00%
- Mass spec
- Not confirmed
- Manufactured
- —
- Lab
- —
Selected variant
$110.00RUO
Retatrutide (LY3437943) is a novel triple-agonist peptide developed by Eli Lilly that simultaneously targets glucagon-like peptide-1 (GLP-1), glucose-
You might also be interested in
Semaglutide
Weight Management
Semaglutide
Dose—
HPLC purity99.0%
FormLyophilized
Pack
